CELCUITY INC. Increase (Decrease) in Accrued Liabilities
CELCUITY INC. (CELC) reported Increase (Decrease) in Accrued Liabilities of $4.26 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2025-11-13
- CELCUITY INC. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was -$2.19M, a 157.34% decline year-over-year.
- CELCUITY INC. increase (decrease) in accrued liabilities for the quarter ending 2025-06-30 was $5.83M, a 203.12% increase year-over-year.
- CELCUITY INC. increase (decrease) in accrued liabilities for the quarter ending 2025-03-31 was $633.00K, a 72.45% decline year-over-year.
- CELCUITY INC. increase (decrease) in accrued liabilities for the quarter ending 2024-12-31 was $5.21M, a 155.39% increase year-over-year.
- CELCUITY INC. increase (decrease) in accrued liabilities for fiscal 2024 was $13.26M, a 172.41% increase from fiscal 2023.
- CELCUITY INC. increase (decrease) in accrued liabilities for fiscal 2023 was $4.87M, a 49.41% increase from fiscal 2022.
- CELCUITY INC. increase (decrease) in accrued liabilities for fiscal 2022 was $3.26M, a 11418.34% increase from fiscal 2021.
- CELCUITY INC. increase (decrease) in accrued liabilities for fiscal 2021 was $28.28K, a 85.14% decline from fiscal 2020.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|---|---|
| 2025-09-30 | -$2.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $3.63M derived: sum of 2 quarters · filed 2025-11-13 | $4.26M 10-Q · filed 2025-11-13 | $9.47M derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2025-06-30 | $5.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $6.46M 10-Q · filed 2025-08-14 | $11.67M derived: sum of 3 quarters · filed 2025-08-14 | $15.50M derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2025-03-31 | $633.00K 10-Q · filed 2025-05-15 | $5.84M derived: sum of 2 quarters · filed 2025-05-15 | $9.67M derived: sum of 3 quarters · filed 2025-11-13 | $11.59M derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-12-31 | $5.21M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $9.04M derived: sum of 2 quarters · filed 2025-11-13 | $10.96M derived: sum of 3 quarters · filed 2025-11-13 | $13.26M 10-K · filed 2025-03-31 | |||
| 2024-09-30 | $3.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $5.75M derived: sum of 2 quarters · filed 2025-11-13 | $8.05M 10-Q · filed 2025-11-13 | $8.05M 10-Q · filed 2024-11-14 | $10.09M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $1.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $4.22M 10-Q · filed 2025-08-14 | $4.22M 10-Q · filed 2024-08-14 | $6.26M derived: sum of 3 quarters · filed 2025-08-14 | $9.28M derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $2.30M 10-Q · filed 2025-05-15 | $2.30M 10-Q · filed 2024-05-15 | $4.34M derived: sum of 2 quarters · filed 2025-05-15 | $7.35M derived: sum of 3 quarters · filed 2025-05-15 | $8.18M derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $5.06M derived: sum of 2 quarters · filed 2025-03-31 | $5.89M derived: sum of 3 quarters · filed 2025-03-31 | $4.87M 10-K · filed 2025-03-31 | |||
| 2023-09-30 | $3.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $3.85M derived: sum of 2 quarters · filed 2024-11-14 | $2.83M 10-Q · filed 2024-11-14 | $3.81M derived: sum of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | $830.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$189.15K 10-Q · filed 2024-08-14 | $797.82K derived: sum of 3 quarters · filed 2024-08-14 | $2.19M derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | -$1.02M 10-Q · filed 2024-05-15 | -$33.14K derived: sum of 2 quarters · filed 2024-05-15 | $1.36M derived: sum of 3 quarters · filed 2024-05-15 | $1.82M derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | $986.97K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $2.38M derived: sum of 2 quarters · filed 2024-03-27 | $2.84M derived: sum of 3 quarters · filed 2024-03-27 | $3.26M 10-K · filed 2024-03-27 | |||
| 2022-09-30 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $1.86M derived: sum of 2 quarters · filed 2023-11-13 | $2.27M 10-Q · filed 2023-11-13 | $2.19M derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | $461.91K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $875.41K 10-Q · filed 2023-08-11 | $798.45K derived: sum of 3 quarters · filed 2023-08-11 | $1.03M derived: sum of 4 quarters · filed 2023-08-11 | |||
| 2022-03-31 | $413.50K 10-Q · filed 2023-05-15 | $336.54K derived: sum of 2 quarters · filed 2023-05-15 | $566.72K derived: sum of 3 quarters · filed 2023-05-15 | $555.54K derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | -$76.96K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $153.22K derived: sum of 2 quarters · filed 2023-03-23 | $142.04K derived: sum of 3 quarters · filed 2023-03-23 | $28.28K 10-K · filed 2023-03-23 | |||
| 2021-09-30 | $230.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $219.00K derived: sum of 2 quarters · filed 2022-11-10 | $105.24K 10-Q · filed 2022-11-10 | $122.98K derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | -$11.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$124.94K 10-Q · filed 2022-08-12 | -$107.20K derived: sum of 3 quarters · filed 2022-08-12 | $39.16K derived: sum of 4 quarters · filed 2022-08-12 | |||
| 2021-03-31 | -$113.76K 10-Q · filed 2022-05-16 | -$96.02K derived: sum of 2 quarters · filed 2022-05-16 | $50.34K derived: sum of 3 quarters · filed 2022-05-16 | $46.39K derived: sum of 4 quarters · filed 2022-05-16 | |||
| 2020-12-31 | $17.74K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $164.10K derived: sum of 2 quarters · filed 2022-03-23 | $160.15K derived: sum of 3 quarters · filed 2022-03-23 | $190.29K 10-K · filed 2022-03-23 | |||
| 2020-09-30 | $146.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $142.41K derived: sum of 2 quarters · filed 2021-11-09 | $172.55K 10-Q · filed 2021-11-09 | $213.39K derived: sum of 4 quarters · filed 2021-11-09 | |||
| 2020-06-30 | -$3.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $26.19K 10-Q · filed 2021-08-11 | $67.02K derived: sum of 3 quarters · filed 2021-08-11 | $53.31K derived: sum of 4 quarters · filed 2021-08-11 | |||
| 2020-03-31 | $30.14K 10-Q · filed 2021-05-10 | $70.97K derived: sum of 2 quarters · filed 2021-05-10 | $57.27K derived: sum of 3 quarters · filed 2021-05-10 | $129.27K derived: sum of 4 quarters · filed 2021-05-10 | |||
| 2019-12-31 | $40.83K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $27.13K derived: sum of 2 quarters · filed 2021-02-16 | $99.13K derived: sum of 3 quarters · filed 2021-02-16 | $111.40K 10-K · filed 2021-02-16 | |||
| 2019-09-30 | -$13.71K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-09 | $58.29K derived: sum of 2 quarters · filed 2020-11-09 | $70.57K 10-Q · filed 2020-11-09 | -$169.84K derived: sum of 4 quarters · filed 2020-11-09 | |||
| 2019-06-30 | $72.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-08-11 | $84.28K 10-Q/A · filed 2020-08-11 | -$156.13K derived: sum of 3 quarters · filed 2020-08-11 | -$186.71K derived: sum of 4 quarters · filed 2020-08-11 | |||
| 2019-03-31 | $12.28K 10-Q · filed 2020-05-07 | -$228.13K derived: sum of 2 quarters · filed 2020-05-07 | -$258.71K derived: sum of 3 quarters · filed 2020-05-07 | -$178.92K derived: sum of 4 quarters · filed 2020-05-07 | |||
| 2018-12-31 | -$240.41K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$270.99K derived: sum of 2 quarters · filed 2020-03-13 | -$191.20K derived: sum of 3 quarters · filed 2020-03-13 | -$44.35K 10-K · filed 2020-03-13 | |||
| 2018-09-30 | -$30.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $49.21K derived: sum of 2 quarters · filed 2019-11-07 | $196.06K 10-Q · filed 2019-11-07 | $417.55K derived: sum of 4 quarters · filed 2019-11-07 | |||
| 2018-06-30 | $79.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $226.64K 10-Q · filed 2019-08-08 | $448.13K derived: sum of 3 quarters · filed 2019-08-08 | $529.26K derived: sum of 4 quarters · filed 2019-08-08 | |||
| 2018-03-31 | $146.85K 10-Q · filed 2019-05-07 | $368.34K derived: sum of 2 quarters · filed 2019-05-07 | $449.46K derived: sum of 3 quarters · filed 2019-05-07 | $517.84K derived: sum of 4 quarters · filed 2019-05-07 | |||
| 2017-12-31 | $221.49K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $302.62K derived: sum of 2 quarters · filed 2019-03-01 | $370.99K derived: sum of 3 quarters · filed 2019-03-01 | $392.31K 10-K · filed 2019-03-01 | |||
| 2017-09-30 | $81.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $149.51K derived: sum of 2 quarters · filed 2018-11-13 | $170.83K 10-Q · filed 2018-11-13 | $237.54K derived: sum of 4 quarters · filed 2018-11-13 | |||
| 2017-06-30 | $68.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $89.70K 10-Q · filed 2018-08-09 | $156.41K derived: sum of 3 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | $21.32K 10-Q · filed 2018-05-14 | $88.03K derived: sum of 2 quarters · filed 2018-05-14 | |||||
| 2016-12-31 | $66.71K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $91.98K 10-K · filed 2018-03-15 | |||||
| 2016-09-30 | $25.26K 10-Q · filed 2017-12-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |